$HTFL News
Last published 1w ago
- 1w agoHTFLAHA 2026: Heartflow Plaque Analysis Associated with 34% Fewer Major CVD Events and Half the Rate of Heart Attack at One Year in Prospective DECIDE RegistryGlobeNewswireFirst plaque tool with prospective outcomes data. Faster, sustained LDL-C control: approximately 50% of patients reached goal by 90 days vs. approximately 35% with CCTA alone. GAMEFILM data highlight high prevalence
- 1w agoHTFLTCT 2026: CT-guided PCI Matches IVUS Outcomes in Randomized P4 Trial; Heartflow PCI Navigator Changes PCI Plans in Approximately 70% of PatientsGlobeNewswireLate-Breaking P4 study, simultaneously published in NEJM, shows CT guidance delivers matched one-year clinical outcomes with shorter procedures, demonstrating pre-procedural CCTA can guide key PCI planning decisions
- 2w agoBSXHTFLBoston Scientific announces results for third quarter 2026PR NewswireMARLBOROUGH, Mass., Oct. 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE:BSX) generated net sales of $5.138 billion during the third quarter of 2026, growing 1.5 percent on a reported, operational1 and
- 3w agoHTFLHeartflow to Report Third Quarter 2026 Financial Results on November 12, 2026GlobeNewswireSAN FRANCISCO, Oct. 19, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced it will release
- 2mo agoHTFLLate Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly HalfGlobeNewswireSAN FRANCISCO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced late-breaking one-year
- 2mo agoHTFLHeartflow to Participate in the Wells Fargo 21st Annual Healthcare ConferenceGlobeNewswireSAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of
- 3mo agoHTFLHeartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceGlobeNewswireSAN FRANCISCO, Aug. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for diagnosing coronary artery disease (CAD), today reported financial results for the second
- 3mo agoHTFLHeartflow to Report Second Quarter 2026 Financial Results on August 13, 2026GlobeNewswireSAN FRANCISCO, July 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the
- 4mo agoHTFLNew Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease ManagementGlobeNewswireHeartflow Plaque StagingTM, the only staging tool based on total plaque volume*, is now included with every Heartflow Plaque Analysis Data from over 36,000 patients validate the accuracy, reproducibility and utility of
- 4mo agoHTFLBFLYTEMIRTC16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart GapPR NewswireEquity Insider News Commentary — Congenital heart disease is the most common birth defect in the world, and the population living with it is growing, ...
- 6mo agoHTFLHeartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 GuidanceGlobeNewswireSAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the first quarter ended
- 6mo agoBFLYCTKBHTFLVCYT+1A Toronto AI-Cardiac Diagnostics Company Just Cleared Three of the Hardest Validation Bars in MedtechGlobeNewswireVMS+™ 4.0 system collects a 2026 Edison Award Gold Medal, advances to NMPA regulatory submission in China, and heads to the AEPC pediatric cardiology meeting in Padua, Italy VANCOUVER, British Columbia, May
- 6mo agoBFLYHTFLMBQIFRXRX+1The Future of Intoxication Detection May Be in Your VoiceGlobeNewswireAUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: The ability to accurately detect drug and alcohol intoxication has long been a persistent challenge across industries, from law enforcement
- 6mo agoHTFLHeartflow to Report First Quarter 2026 Financial Results on May 14, 2026GlobeNewswireSAN FRANCISCO, April 23, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for the
- 6mo agoBFLYEWHTFLIRTCThe Quiet Shift Replacing Million-Dollar Heart Scanners With SoftwareGlobeNewswireVANCOUVER, British Columbia, April 16, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com News Commentary – The global AI cardiology market is on track to hit $2.78 billion this year and climb past $14 billion by 2034, and the
- 7mo agoHTFLHeartflow Files Patent Infringement Lawsuit Against CleerlyGlobeNewswireMOUNTAIN VIEW, Calif., April 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that it has filed a patent
- 7mo agoBEATHTFLHYPRGEHCHow Decentralized AI is Unlocking Value in Cardiac DiagnosticsPR NewswireUSANewsGroup.com News Commentary – Heart disease is a quiet crisis that is draining healthcare resources worldwide, currently costing the European...
- 8mo agoHTFLHeartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention PlanningGlobeNewswireThree presentations at ACC reinforce Heartflow's AI-powered technology predicts MACE, drives superior lipid outcomes and results in cost-effective care First patient enrolled in pioneering NAVIGATE-PCI Registry assessing
- 8mo agoHTFLHeartflow to Participate in the Morgan Stanley Technology, Media & Telecom ConferenceGlobeNewswireMOUNTAIN VIEW, Calif., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will
- 9mo agoHTFLHeartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026GlobeNewswireMOUNTAIN VIEW, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for
- 9mo agoHTFLHeartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional AthletesGlobeNewswireMOUNTAIN VIEW, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced a significant expansion of its
- 9mo agoATRCCBLLEWHTFLAI Diagnostics: The End of the High-Cost Imaging EraGlobeNewswireVANCOUVER, British Columbia, Jan. 16, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The AI medical imaging market is entering a phase of explosive 25.8% annual growth through 2034[1]. This systemic
- 10mo agoHTFLHeartflow to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswireMOUNTAIN VIEW, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members
- 10mo agoHTFLHeartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CADGlobeNewswireMOUNTAIN VIEW, Calif., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), announced the American College of Cardiology (ACC) and
- 11mo agoHTFLCBLLMDTABTAI Diagnostics Hit Critical Mass as Hospitals Race to Cut CostsPR NewswireUSANewsGroup.com News Commentary – Point-of-care infectious disease diagnostics valued at $53 billion in 2024 are projected to nearly double by 2033, ...
- 11mo agoHTFLHeartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery DiseaseGlobeNewswireMOUNTAIN VIEW, Calif., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), announced two new analyses from FISH&CHIPS, a
- 11mo agoHTFLHeartflow to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewswireMOUNTAIN VIEW, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today announced that members
- 12mo agoHTFLHeartflow Reports Third Quarter 2025 Financial ResultsGlobeNewswireMOUNTAIN VIEW, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in artificial intelligence (AI) technology for coronary artery disease (CAD), today reported financial
- 1y agoHTFLAHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk StratificationGlobeNewswireNEW ORLEANS, Nov. 09, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced late-breaking data from the FISH&CHIPS Study
- 1y agoHTFLHeartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025GlobeNewswireMOUNTAIN VIEW, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data
- 1y agoHTFLHeartflow to Report Third Quarter 2025 Financial Results on November 12, 2025GlobeNewswireMOUNTAIN VIEW, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will release financial results for
- 1y agoHTFLNew Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI PlanningGlobeNewswirePLAN CALCIUM study to be presented at TCT 2025 conference highlights how AI-powered plaque analysis can inform lesion preparation and calcium modification planning NAVIGATE-PCI registry to enroll approximately 2,500
- 1y agoHTFLHeartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis PlatformGlobeNewswireMOUNTAIN VIEW, Calif., Sept. 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it has received U.S. Food and Drug
- 1y agoHTFLHeartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare ConferenceGlobeNewswireMOUNTAIN VIEW, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), the leader in AI technology for coronary artery disease (CAD), today announced that members of management will
- 1y agoHTFLHeartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional SharesGlobeNewswireMOUNTAIN VIEW, Calif., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the closing of its upsized initial public
- 1y agoHTFLHeartflow, Inc. Announces Pricing of Upsized Initial Public OfferingGlobeNewswireMOUNTAIN VIEW, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (NASDAQ:HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public
- 1y agoHTFLHeartflow Plaque Analysis to be Covered by UnitedHealthcare Plans NationwideGlobeNewswireMOUNTAIN VIEW, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Heartflow, Inc., the leader in AI technology for coronary artery disease (CAD), today announced Heartflow Plaque Analysis will be covered by UnitedHealthcare